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Aims: The aim of this review is to assess the role of robotics in pelvic surgery in terms of outcomes. We
have also highlighted the issues related to training and future development of robotic systems.
Materials and methods: We searched MEDLINE, EMBASE and the Cochrane Databases from 1980 to 2009
for systematic reviews of randomised controlled trials, prospective observational studies, retrospective
studies and case reports assessing robotic surgery.
Results: During the last decade, there has been a tremendous rise in the use of robotic surgical systems
for all forms of precision operations including pelvic surgery. The short-term results of robotic pelvic
surgery in the ﬁelds of urology, colorectal surgery and gynaecology have been shown to be comparable to
the laparoscopic and open surgery. Robotic surgery offers an opportunity where many of these obstacles
encountered during open and laparoscopic surgery can be overcome.
Conclusions: Robotic surgery is a continually advancing technology, which has opened new horizons for
performing pelvic surgery with precision and accuracy. Although its use is rapidly expanding in all
surgical disciplines, particularly in pelvic surgery, further comparative studies are needed to provide
robust guidance about the most appropriate application of this technology within the surgical
armamentarium.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Minimally invasive surgery has expanded rapidly since the ﬁrst
laparoscopic cholecystectomy.1 This was driven by the quest for
smaller incisions, faster recovery, less stay related complications
and improved dexterity, which gained further momentum as
a result of the introduction of robotics to surgery. The era of robotic
surgery dawned in early 1990s,2 and many of the current systems
emerged by the end of that decade. These include the ‘master-slave
robotic systems’ such as the da Vinci and ZEUS surgical systems,
which allowed entry to an era where poor visibility, hand tremors,
limited freedom of movement and bulky instruments were not
a problem.3
The daVinci system, describedas the ‘‘tele-presence surgery’’was
developed by NASA and the US defence department with the aim to
allow surgeons to operate on wounded soldiers from a remoted).
ciates Ltd. Published by Elsevier Ltlocation. This system permitted real-time video image contact
between the patient and surgeon. The da Vinci is not a fully auto-
mated robot in the true sense but is in fact a ‘‘master-slave’’ system
that allows the surgeon to control the function of the robot. It
consists of a cartwith robotic armsdelivering a variety of articulating
instruments including cameras. At the console is a pair of binoculars,
which displays 3D video image of the operating ﬁeld. As the surgeon
views the surgical ﬁeld through these binoculars, he descends into
the virtual 3D operative ﬁeld and perceives himself to be inside the
patient surrounded by the abdominal or thoracic walls.3
The da Vinci robotic system has been found to be extremely
useful to approach and intervene in narrow cavities such as pelvis
and it is gradually becoming a common practice (Fig. 1). The
advantages further include stable camera platform to eliminate
hand-tremor from a camera holder; hand-like motions of the
instruments permitting a variety of tasks not possible with tradi-
tional straight laparoscopic instruments to facilitate dissection;
a three-dimensional virtual operative ﬁeld, with improved spatial
awareness as compared to standard two-dimensional imaging
systems; an ergonomically comfortable position to sit at the remoted. All rights reserved.
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Fig. 1. Pelvic Robotic surgery in historical perspective.
K. Ahmed et al. / International Journal of Surgery 7 (2009) 431–440432telerobotic console, reducing the shoulder and back fatigue asso-
ciated with prolonged laparoscopic operations.4 Conversion and
complication rates are low and short-term outcomes are compa-
rable to that of conventional laparoscopic surgery.5
We reviewed the literature with the aim to assess the current
role of robotics in pelvic surgery (colorectal surgery, urology and
gynaecology) in terms of its utility and outcomes. Issues pertaining
to safety, reliability of robotic systems, training in robotic surgery
and the future developments are also discussed.
2. Methods
We searched MEDLINE, EMBASE and the Cochrane databases
from 1980 to 2009 for systematic reviews of randomised controlled
trials, prospective observational studies, retrospective studies and
case reports assessing robotic surgery. The search strings were
deﬁned by a combination of keywords including ‘robotics’ or ‘robot’
or ‘robot-assisted’ or ‘da Vinci’. Additional search was performed
for each of gynaecology, colorectal surgery, urology and pelvic
surgery. The search was limited to articles in English language and
relevant studies were evaluated including the reference lists.
3. Role in colorectal surgery
The ﬁrst series of robotically assisted laparoscopic colectomy
were published in March 2001.6 Since then robotic assistance has
been employed in hemicolectomies, sigmoid colectomies, procto-
pexies, low anterior resections and abdominoperineal resections
(Table 1).7–9
Robot assisted anterior and abdominoperineal resections have
been reported by various authors. D’Annibale et al. reported
a comparison of 53 robotic and 53 laparoscopic procedures per-
formed for colorectal diseases.7 Although pelvic surgeries were not
compared alone, 10 anterior resections and 1 abdominoperineal
resection were performed in the robotic group and 15 anterior
resections were performed in the laparoscopic group. No differ-
ences were seen in complication rates, estimated blood loss and
lymph node harvest rates. Median length of hospital stay was 2.5
days in the robotic surgery group, vs. 3 days in the laparoscopic
cohort. There was no signiﬁcant difference in actual operating time
(robotic group, 240 61 min; laparoscopic group, 222 77 min),
but system and patient setup time (robotic group, 2412 min;
laparoscopic group,18 7 min; p¼ 0.002), were relatively longer in
the robotic group.7
Spinoglio et al. compared 50 robotic to 161 laparoscopic colo-
rectal resections.10 Similar to D’Annibale et el, pelvic surgeries were
not compared separately, but there were 19 anterior resections and
1 abdominoperineal resection in the robotic group and 26 anterior
resections and 7 abdominoperineal resections in the laparoscopic
groups. There was a signiﬁcant longer operative time in the robotic
group (383.8 vs. 266.3 min, p< 0.001), but there were no differ-
ences in short-term outcomes such as restitution of gut function
and length of hospital stay.
Pigazzi’s group in California, reported by Hellan et al. and
Anderson et al.,11,12 performed 39 consecutive robotic assisted
laparoscopic rectal resections with total mesorectal excision (TME)
for primary rectal cancer. The study included the results of 22 low
anterior, 11 intersphincteric and 6 abdominoperineal resections.
The median operative time was 285 minutes (range 180–540 min)
and a median robotic TME time of 60 minutes (range 35–135 mins).
One patient required conversion to open surgery (conversion rate
2.6%). Ninety-ﬁve per cent of patients had a colo-anal anastomosis
within 5 cm of the anal verge. Six patients had major postoperative
complications (15%), including four anastomotic leaks, all requiring
reoperation (12% leak rate), one delayed ﬁstula and one patientwith a neurogenic bladder and wound dehiscence. The median
length of stay was 4 days. Total mesorectal excisionwith autonomic
nerve preservation was achieved in all of the patients, and all
circumferential and distal resection margins were negative. One
patient died four months after surgery due to unrelated causes.
There were no peri-operative (30-day) or cancer-related deaths.11,12
The largest series of robotic-assisted low anterior resections has
been described by Baik et al.13–15 In this prospective comparative
non-randomised study consecutive rectal cancer patients were
treated by laparoscopic low anterior resection (L-LAR) (n¼ 57) or
robotic low anterior resection (R-LAR) (n¼ 56). There was no
signiﬁcant difference between mean operating time (L-LAR
191.165.3 vs. R-LAR 190.145.0 min). Patients who had L-LAR
had signiﬁcantly higher mean length of hospital stay (7.6 3.0 vs.
5.71.1 days, p¼ 0.001), open conversions (6 vs. 0 patients,
p¼ 0.013) and serious complications (11 vs. 3 patients, p¼ 0.025).
Serious complications included anastomotic leakage with 4 (7%)
leaks in the laparoscopic group compared to 1 (2%) leak in the
robotic group. TME was signiﬁcantly better in the R-LAR group in
comparison to the L-LAR group (52 complete, 4 nearly complete vs.
43 complete, 12 nearly complete, 2 incomplete, p¼ 0.033).
However there was no difference in circumferential resection
margin involvement (L-LAR 5 vs. R-LAR 3 involved).
The studies by Pigazzi et al. and Baik et al. demonstrate that
robotic assisted rectal resections with TME can be performed safely
and effectively using robotic assistance with lower serious
complication rates than laparoscopic surgery. The reported leak
rates of 2–12% is comparable to the 6–16% rate reported in open
series and 13–19% in laparoscopic series.16,17 The low conversion
rate and reduced length of hospital stay in robotic surgery has
important implications for clinical outcome.
4. Role in urological surgery
The fastest growing application of robotic pelvic surgery is in
urological procedures such as prostatectomy and cystectomy.18–20
4.1. Robot-assisted radical prostatectomy for prostate cancer
Presently, radical prostatectomy (RP) is the most commonly
performed robot assisted laparoscopic procedure (Table 2). Robotic
RP (RRP) has traditionally been regarded as time consuming rela-
tive to open surgery. However, with increasing experience and
Table 1
Published series for robotic-assisted colorectal resections.
Author Institution Year n Indications System Robot-assisted
(RALC) or Total
Robotic (TRLC)
Operative time
min mean þ/ SD or
median (range)
Conversion % Mortality % Complications LOS days mean
þ/ SD or
median (range)
Giulianotti60 Misericordia Hospital,
Grosseto, Italy
2003 16 Colon cancer n¼ 6 da Vinci RALC 211 (90–360) 0 0 0 NR
Rectal cancer n¼ 6
Anal melanoma n¼ 2
Caecal Lipoma n¼ 2
Hanly61 Johns Hopkins
University, Maryland,
USA
2004 35 Diverticular disease and
benign polyps
da Vinci RALC 177 14 NR NR NR
Anvari62 McMaster University,
Ontario, Canada
2004 10 Colon cancer n¼ 4 Zeus RALC 155 14 0 0 0 5.3 0.95
Rectal cancer n¼ 2
Benign n¼ 4
D’Annibale7 Camposampiero,
Padova, Italy
2004 53 Colon cancer n¼ 14 da Vinci TRLC 240 61 9 0 2 surgical – needed
reoperation 2 general
10 4
Rectal cancer n¼ 8
Benign disease n¼ 31
Braumann6 Humboldt University,
Berlin, Germany
2005 5 Colon cancer n¼ 2 da Vinci RALC 201 (80–300) 40 0 1 enterovesical ﬁstula 13.6 4.7
Rectal cancer n¼ 1
Diverticulosis n¼ 2
DeNoto8 North Shore University
Hospital, New York, USA
2006 11 Sigmoid cancer and
Sigmoid diverticulosis
da Vinci TRLC 197 (145–345) 9 0 0 3.4 0.5
Ballantyne9 Hackensack University,
New Jersey, USA
2006 16 All benign disease da Vinci RALC 249 (180–330) 6 0 1 reoperation for
bleeding 2 prolonged
ileus
4.5 (2–10)
Rawlings
(Right
colectomies)5
University of Illinois,
Illinois, USA
2007 Robotic 17
Laparoscopic 15
Polyps n¼ 20 (6/14) da Vinci TRALC vs.
laparoscopic
Robotic
218.9 44.6
Laparoscopic
169.2 37.5
Robotic 0
Laparoscopic
13.3
0 Anastamotic leak,
postoperative bleed,
ileus
Robotic
5.2 5.8
Laparoscopic
5.5 3.4
Cancer n¼ 8 (2/6)
Diverticulitis n¼ 2 (0/2)
Carcinoid n¼ 1 (1/0)
Crohn’s disease n¼ 1 (0/1)
‘Rawlings
(Sigmoid
colectomies)5
University of Illinois,
Illinois, USA
2007 Robotic 13
Laparoscopic 12
Diverticulitis n¼ 18 (8/10) da Vinci TRALC vs.
laparoscopic
Robotic 225.2 37.1
Laparoscopic
199.4 44.5
Robotic 15.4
Laparoscopic 0
0 Caecal injury, tranverse
colon injury, anasomotic
leaks, wound infection
Laparoscopic 6.6 8.3
Robotic
6.0 7.3Cancer n¼ 5 (3/2)
Polyp n¼ 2 (2/0)
Pigazzi11,12 City of Hope National
Medical Center,
California, USA
2007 39 All rectal cancer da Vinci RALC 285 (180–540) 12.1 0 Intra-operative bleeding,
anastomotic leaks,
reoperation, wound
infection, urinary
disorder, ileus
4 (2–22)
Spinoglio10 SS Antonio e Biagio,
Alessandria, Italy
2008 Robotic 50
Laparoscopic 161
Cancer n¼ 172 (44/128)
Benign n¼ 39 (6/33)
da Vinci RALC vs.
laparoscopic
Robotic: 383.8
Laparoscopic: 266.3
Robotic 4
Laparoscopic 4
0 Incisional hernia, lung
atelectasia, wound
infection, arm phlebitis,
brain stroke,
anastomotic leaks
Robotic 7.74
Laparoscopic
8.31
Baik15 Yonsei University College
of Medicine, Seoul, Korea
2009 Robotic 56
Laparoscopic 57
All rectal cancer da Vinci RALC vs.
laparoscopic
Robotic 190.1 45.0
Laparoscopic
191.1 65.3
Robotic 0
Laparoscopic 10.5
0 Intraluminal bleeding,
anastomotic leak, ileus
Robotic
5.7 1.1
Laparoscopic
7.6 3.0
K
.A
hm
ed
et
al./
Internation
al
Journ
al
of
Surgery
7
(2009)
431–440
433
Table 2
Published series for robotic prostatectomy.
Author Year n Operative time min
mean þ/ SD or
median (range)
Mean estimated
blood loss (ml)
Overall tumour
rate (%) (pT2/pT3)
Complications (%) Positive Surgical
Margin rate (%)
Ahlering63 2003 45 209 (150–600) 145 (25–350) 60/35 13.3 35.5
Bentas64 2003 40 500 (246–780) 570 (100–2500) 62.5/37.5 32.5 30
Tewari65 2003 200 160 (71–315) 153 (25–750) 87/13 3.5 6
Wolfram66 2003 81 250 (150–390) 300 (100–1500) 68.5/31.5 – 22
Ahlering67 2004 200 – 108 (25–400) 72/26 6.7 20.4
Cathelineau68 2004 105 180 (120–290) 500 (150–2000) 71/29 – 22
Ahlering69 2005 109 70 92 (25–250) – 8 13
Ahlering71 2005 100 247 (160–645) 120 (25–400) 75/25 9 25
Chien72 2005 56 356 (240–480) 356 (25–1200) 82/18 9 10.7
Costello73 2005 122 – – 80/20 19 16.3
Joseph74 2005 50 202 þ/ 38 206 þ/ 63 88/12 8 12
Menon75 2005 76 115 102.3 95 – 3
Patel76 2005 200 141.2 75.1 78/19 1 10.5
Hu77 2006 322 186 (114–528) 250 (50–1600) – 14.6 –
Menon78 2006 1142 154 (71–387) 142 (10–750) 77.7/22 2.3 13
Patel79 2006 500 130 (51–330) 50 (10–300) 78/20 – 9.4
Badani80 2007 2766 154 (71–387) 142 (10–1350) 77.7/22 14.9 12.3
Tewari81 2008 215 150 (120–240) 150 – – 6.5
Tewari82 2008 700 – – 83.5/14.1 – 5.2
Rocco83 2009 120 215 (165–450) 200 (50–2000) 73/24 – 22
K. Ahmed et al. / International Journal of Surgery 7 (2009) 431–440434reﬁnements, the operating times are becoming comparable or even
shorter. The mean blood loss after robotic surgery (152 mL) is
signiﬁcantly less than open (697 mL) and laparoscopic (406 mL)
prostatectomy.21 As a consequence, transfusion rate has been
shown to be much lower than laparoscopic and open approaches.
Themean catheter time for robotic procedure is similar to open and
laparoscopic surgery.21
Most of the robotic prostate procedures are carried out for
cancers. Cancer control remains the principal desirable outcome for
any procedure with intent to cure. Berryhill et al.21 used positive
margin rate (PSM) to imply that the entire tumour was not excised.
The mean PSM for robotic RPs was 12.5%, compared with 19.6% and
23.5% for laparoscopic RPs (LRP) and open RPs, respectively. The
open and laparoscopic series included greater numbers of pT3Table 3
Published series for robotic cystectomy.
Author Year n Operative time min
mean þ/ SD or
median (range)
Mean es
blood lo
Beecken84 2003 1 Total 510 200
Menon26 2003 14 Cystectomy 140 150
Ileal conduit 120
Neobladde 168
Menon27 2004 3 Cystectomy 160 166
Ileal conduit 130
Neobladder 180
Balaji25 2004 3 Total 691 250
Hemal85 2004 23 Cystectomy 140 200
Urinary diversion 150
Pruthi86 2007 Total 366 313
Murphy87 2008 23 397 þ/ 83.8 278 þ/
Wang70 2008 54 Open 300
Robotic 390
Open 75
Robotic
Lee88 2009 6 – 296 (ranlesions, which could have an impact on negative margin rates. The
overall complication rate for RRPs has been shown to be 6.6%,
compared with 15.6% and 10.3% for laparoscopic RPs and open RPs,
respectively. However, the gold standard randomised controlled
trial is needed to further evaluate this.
Postoperative urinary continence is another critical outcome
comparison to be considered. Robotic assisted radical prostatec-
tomy outcomes for urinary continence range from 73% to 91% at 3
months, 98% at 12months and 100% beyond 18months. In contrast,
laparoscopic assisted prostatectomy results are 51–94% at 3months
and 60–98% at 12 months. Long-term results for LRP are not
available. For open prostatectomies, urinary continence results are
54%–70.9%, 60.5–92.1% and 58%–98.5% respectively at 3 months, 12
months and beyond 18 months follow-up.21–23timated
ss (ml)
Urinary diversion Surgical Margin
Extracorporeal Negative
Extracorporeal Negative
Extracorporeal Negative
Intracorporeal Negative
Extracorporeal Negative
Extracorporeal Negative
229 Ileal conduit 19 Negative
Studer pouch
reconstruction 4
0
400
Open: Positive
margins: 14% in
open and 6% in robotic
Ileal conduit 11
Indiana pouch 5
Orthotopic neobladder 5
Robotic:
Ileal conduit 17
Indiana pouch 3
Orthotopic neobladder 12
ge 125–500) Ileal conduit 5 Negative
Neobladder 1
Table 4
Published series for robotic procedures in gynaecology.
Author Year n Study Type Procedure Estimated
blood loss (ml)
mean þ/ SD or
median (range)
Operative time
(min) mean
þ/ SD or
median (range)
Organ/
mass
weight
(gm)
Indications
for surgery
Complications
Degueldre36 2000 8 Series Tubal
reanastomosis
– 140 – – –
Cadiere89 2001 28 Series Tubal
reanastomosis
– 125 (108–244) – – None
Diaz-
Arrastia28
2002 11 Series Hysterectomy 300 (50–1500) 270–600 – Recurrent
cervical
intraepithelial
neoplasia-3,
pelvic mass,
postmenopausal
bleeding,
endometrial
carcinoma,
ovarian
carcinoma
Conversion to
laparotomy
n¼ 1
Molpus35 2003 1 Series Ovarian
transposition
– Adhesiolysis
108, Mobilization
of the
infundibulopelvic
ligaments and
suturing the
ovaries into
place 42
– Stage I-B1
cervical squamous
cell carcinoma
(previous radical
cystectomy)
–
Advincula34 2004 35 Series Myomectomy 169 198.7 230.8 þ/83 223.2–
244.1
Intramural and
subserous
leiomyoma
Converted to
laparotomy
n¼ 2, difﬁculty in
enucleation
due to
lack of tactile
feedback n¼ 1,
cardiogenic
shock n¼ 1
Beste90 2005 11 Series Hysterectomy 25–350 148–277 49–227 Menorrhagia,
dysmenorrhea,
pelvic pain,
uterine ﬁbroids
Conversion to
laparotomy
n¼ 1,
Cystotomy n¼ 1
Fiorentino29 2006 20 Series Hysterectomy 81 200 98 Menorrhagia,
pelvic pain
Conversion
to laparotomy
n¼ 2,
Vaginal cuff
bleeding n¼ 1
Reynolds30 2006 16 Series Hysterectomy 72.5 (50–300) 242 (170–432) 131.5
(30–327)
Abnormal
uterine bleeding,
chronic pelvic pain,
uterine ﬁbroids,
adenomyosis,
dysmenorrhea,
pelvic mass.
Pneumonia n¼ 1,
Bowel and
bladder
injury n¼ 1,
Vaginal
cuff hematoma
n¼ 1, Wound
cellulitis n¼ 1
Sert91 2006 15 Comparative
(Robotic and
Laparoscopic)
Radical
Hysterectomy
71(median) 241(median) – Early-stage
cervical carcinoma
Advincula92 2007 58 Retrospective
case matched
analysis
Myomectomy Robotic
myomectomy
(RM): 195.7
 228.6
RM:
231.4 85.1
RM:
227.86
 247.54
Symptomatic
leiomyoma
–
Open
myomectomy
(OM): 364.7
 473.3
OM:
154.4 43.1
223.76
 228.28
Kim93 2008 10 Case series Radical
hysterectomy
355
(mean)
207 (mean) – Early stage
carcinoma
No conversions
Fanning32 2008 20 Radical
hysterectomy
300
(median)
310 (median) – Early stage
carcinoma
–
Seamon94 2008 105 Series Hysterectomy
and pelvic–aortic
lymphadenectomy
99  83 242  50 – Stage I or occult
Stage II endometrial
carcinoma
Conversion
rate 13%
Ko95 2008 16 Robotic
vs. 32 Open
Comparative Radical
hysterectomy
82 vs. 666 290 vs. 239 – Stage 1A2 or IBI
endometrial cancer
No conversions
(continued on next page)
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Table 4 (continued )
Author Year n Study Type Procedure Estimated
blood loss (ml)
mean þ/ SD or
median (range)
Operative time
(min) mean
þ/ SD or
median (range)
Organ/
mass
weight
(gm)
Indications
for surgery
Complications
Boggess96 2008 Open (138)
vs. Lap (108)
vs. Robotic
(103)
Comparative Total
hysterectomy
TAH:
266 184
TAH: 146.5 – Stage IA to IVA/IVB
endometrial cancer
Conversion rate: 2.9%
TLH:
145.5 105.6
TLH: 213
TRH:
74.5 101.2
TRH: 191
Boggess97 2008 Robotic (51)
vs. open (49)
Case control Type III radical
hysterectomy
RAH:
96.5 85.5
RAH: 211 45.5 – Stage IA2 to IB2 –
ORH:
416.8 188
ORH: 247.8 49 endometrial
cancer
Bell45 2008 Robotic (40)
vs.
Comparative Radical
hysterectomy
RH:166 RH: 184 RH: 136 – –
Open (40)
vs.
OH: 316 OH: 108.6 OH: 155.6
Lap (30) LH: 253 LH: 171 LH: 138.5
Nezhat98 2008 Robotic (13)
vs.
Lap (30)
Comparative Radical
hysterectomy
and pelvic
lymphadenectomy
RRH: 157 RRH: 323 – Cervical
carcinoma
–
LRH: 200 LRH: 318
Veljovich99 2008 118 Series,
Non-comparative
Hysterectomy
 lymphadencectomy,
staging
lymphadenectomy
71.3 213 104.8 Cervical
cancer and
endometrial
cancer
Conversion to
laparotomy n¼ 2
Magrina100 2008 Robotic (27)
vs. Lap (31)
vs. Open (35)
Comparative Radical hysterectomy RRH:
133 108.5
RRH:
189.6 43.5
RRH:
122.4
Cervical
cancer and
endometrial
cancer
No conversions
LRH:
208.4 105.4
LRH:
220.4 37.5
LH:
122.8
ORH:
443.6z 253
ORH:
166.8 33.2
ORH:
274.6
Lowe31 2009 42 Multicentre,
Non-comparative
Robotic-assisted
type II (n¼ 10) and
type III (n¼ 32)
radical hysterectomy
50 (median) 215 (median) – Stage IA2 (n¼ 7),
Stage I-B1 (n¼ 27),
Stage IB2 (n¼ 6)
Conversion
rate 2.4%
TAH: Total abdominal hysterectomy; TLH: Total laparoscopic hysterectomy; TRH: Total robotic hysterectomy; RAH: Robotic assisted hysterectomy; ORH: Open radical
hysterectomy; RRH: Robotic radical hysterectomy; LRH: laparoscopic radical hysterectomy; ORH: Open radical hysterectomy.
K. Ahmed et al. / International Journal of Surgery 7 (2009) 431–440436Along with continence, sexual potency is a key outcome in
determining quality of life after prostatectomy. With RRP,
depending upon whether patients had unilateral or bilateral nerve
sparing surgery, potency at 12 months has been reported to be
14.3–61% and 24.4–97% respectively. With LRP, 35–64% and 43–
78.9% patients reported to have regained potency at 12 months
with unilateral and bilateral nerve sparing surgery, respectively.
Similar procedures with open prostatectomy show 16.7–53% and
36.7–86% results.21 The interpretation of these results though
difﬁcult, shows an inclination towards RRP in producing more
consistent results. A large scale randomised study is needed to
establish clear beneﬁts of one mode over the other.21
4.2. Robot-assisted radical cystectomy and urinary diversion
Robotic surgery is being utilized in radical cystoprostatectomy
for male patients with bladder cancer and both standard and uterus
sparing radical cystectomy in female patients (Table 3). Robotic
radical cystectomy (RRC) is typically offered to patients with organ-
conﬁned bladder cancer as determined by preoperative clinical,
pathological and radiographic ﬁndings. Presence of extensive
lymphadenopathy, locally advanced disease, uncorrected coagul-
opathy, and obesity are relative contraindications for RRC.24Majority of surgeons use extracorporeal approach for reconstruc-
tion. However, a few who opt for purely robotic approach ﬁnd the
intracorporeal suturing of the ureteroileal anastomosis, neobladder
anastomosis, and urethro-neobladder anastomosis easier. In
a reported series of three patients the operative time for intra-
corporeal construction of ileal conduit was more than 10 hours.25
However, Menon et al. clearly showed that operating time could be
reduced with extracorporeal reconstruction of the urinary diver-
sion.26,27 Long-term functional and oncological outcomes of RRC in
a larger series of patients remain awaited. To date nearly 300 cases
have been performed worldwide.
5. Role in gynaecological surgery
The approaches by which gynaecological procedures are per-
formed have also evolved. This is evident in transformation of
hysterectomy, myomectomy, tubal reanastomosis and ovarian
transposition from open trans-abdominal and vaginal approaches
to laparoscopic techniques and then the robotic approach (Table 4).
Several authors have evaluated robot-assisted gynaecological
procedures. Diaz-Arrastia et al.,28 were the ﬁrst to report a series of
robotic assisted hysterectomy in 16 patients.28 The operative time
ranged from 270 to 600 min and the average blood loss was 300 ml.
K. Ahmed et al. / International Journal of Surgery 7 (2009) 431–440 437The range of average hospital stay was 1–3 days. In this series, the
posterior culdotomy and ligation of the cardinal and uterosacral
ligament complexes were performed vaginally to complete the
hysterectomy. Subsequently, others reported similar outcomes
which were comparable to conventional laparoscopic hysterec-
tomy.29 Reynolds et al. reported the ﬁrst series of 16 consecutive
patients who underwent either type IVE robot-assisted laparo-
scopic hysterectomy (American Association of Gynaecologic Lapa-
roscopists’ classiﬁcation) or Laparoscopic Supracervical
Hysterectomy III hysterectomy (i.e. totally laparoscopic supra-
cervical procedure with removal of the uterine corpus, including
division of the uterine arteries). The mean uterine weight was
131.5 g (range 30–327 g). Median operating time was 242 minutes
(range 170–432) with an average estimated blood loss of 96 ml
(range 50–300 ml). One patient had delayed thermal bowel injury,
2 developed infections, and 1 had a vaginal cuff hematoma. The
median length of hospital stay was 1.5 days.30 From the results of
above mentioned studies it can be established that the short-term
outcomes of the robotic assisted procedures are comparable to
laparoscopic and open procedures.
Lowe et al. in 2009, reported results of the largest multi-insti-
tutional study using da Vinci robot in gynaecologic oncology.31 A
total of 42 patients (median age of 41 and a median BMI of 25.1)
who were included in the study who underwent a robotic-assisted
type II (n¼ 10) or type III (n¼ 32) radical hysterectomy for early
stage cervical cancer. The authors reported various outcome vari-
ables such as median operative time (215 min), median estimated
blood (50 ml), median lymph node count (n¼ 25) and the median
hospital stay (1 day). Positive lymph nodes were detected in 12% of
the patients. Intra-operative complications (4.8%) included one
conversion to laparotomy and one ureteral injury. Postoperative
complications included a DVT (2.4%), infection (7.2%), and bladder/
urinary tract complication (2.4%). The reported conversion rate to
laparotomy was 2.4%.31 Fanning et al. in their study (radical
hysterectomy, n¼ 20) reported long term results. Ninety of their
patients were disease free after 2 years.32
Surgical technique employing robot-assistance allows the
surgeons to overcome difﬁculties encountered during conventional
laparoscopic hysterotomy, enucleation, repair, and extraction.33
Advincula et al.,34 in a series involving 35 patients, have further
demonstrated comparable operating time, blood loss and hospital
stay to laparoscopic surgery.34 Other applications of robotic surgery
in gynaecology include tubal reanastomosis, cancer staging and
abdominal sacrocolpopexy.30,35–376. Training of surgeons in robotic surgery
Technological advances in the ﬁeld of surgery are pacing at
a rate much faster than that in surgical training. The reduction in
training hours poses an additional challenge to training the future
surgeon in newer technologies including robotics. Therefore the
need to speed up the learning curve of trainees is more imminent
than ever. In Europe there are several centres where trainees can
learn robotic surgical techniques on live animal models. Although,
these models provide a simulation experience comparable to real
patients, resource limitation and ethical concerns can be a deter-
rent inwider application of these trainingmethods. In view of these
issues, there is an urgent need to research into virtual reality and
synthetic models for training and accreditation. Fortunately, da
Vinci robotic virtual reality simulators are available which can be
used not only to teach robotic skills but can also be used to differ-
entiate between expert and novice surgeons.38 Some centres have
demonstrated that robotic surgery training can be implemented in
structured training programmes.39 However, trainers face newchallenges of teaching trainees to assist and perform surgery when
not physically standing at the operating room table.40
7. Safety and reliability
Robotic surgery has emerged as a feasible option for routine
surgical procedures in the past few years. There have been studies
looking into reported malfunctions and associated patient harm.
The review ofMAUDE (Medical Device Reports) database of the FDA
(Food and Drug Administration) from 2000 to August 2007 repor-
ted an overall failure rate of 0.38% of which mere 4.8% were asso-
ciated with patient injury.41,42 No intra-operative device failures
were observed in a study by Zorn et al, involving 725 robotic
prostatectomies in a single centre.42 Moreover, the da Vinci robot
has proven its safety and efﬁcacy in a randomised clinical trial
involving 200 patients and has hence been approved by FDA.3
8. Cost of robotic surgery
The use of robotics in pelvic surgery is increasing but the cost
(da Vinci S system costs approximately V1.5 million) remains
a major limiting factor.43 Eight hundred and sixty eight units were
sold worldwide until early 2008, 647 in the United States, 148 in
Europe and 72 in rest of the world (Intuitive Surgical).
The overall cost of robotic practice is variable for different
procedures. The direct procedural cost has been reported to be less
for the open (median $2322) than the robotic assisted prostatec-
tomy (median $3352). However, the total hospital cost for a robotic
procedure (median $9343) is less than the open (median $9724).44
This may be due to the short hospital stay and relatively less stay
related complications. For colorectal surgeries, Rowling et al, who
compared costs of robotic assisted colonic resections with
conventional laparoscopic resections, found that the total hospital
expenditures for all types of resections were higher for robotic
procedures as compared to laparoscopy.5 In gynaecological surgery,
staging laparotomy prior to hysterectomy costs around $12,943.60,
whereas that for standard laparoscopy and robotic procedures cost
$7569.80 and $8212.00 respectively. Total hospital cost for robotic
surgery is less than the open surgery.45
Clearly in all major pelvic surgeries, despite initial cost of setting
up a robot and higher operative expenditures, the total spending
per patient is comparable to the laparoscopic procedures due to
reduced hospital stay and fewer stay related complications. With
time, as the technology is becoming cheaper; the costs will reduce
rapidly.
9. Current limitations of robotic technology
The excursion arcs of the robotic arms and the length of the
surgical instruments are potential limitations of the da Vinci
system. Some difﬁculties are reported with the robotic instruments
in reaching higher up to the splenic ﬂexure and down into the
pelvis. The robotic arms cannot self-adjust around the bed to allow
the surgeon access to more than one quadrant of the abdominal
cavity at one time. Hence to perform dissections in different areas
may require repositioning of the surgical cast during various stages
of the operation. Moving the da Vinci system is time consuming
and difﬁcult because the robotic devices are heavy and bulky. To
address this issue, recently a new generation da Vinci S robot has
been introduced with improved resolution screen enhancing user-
interface. Also, it consists of a motorised patient cart and efﬁcient
mounts for faster patient docking. With the 4th arm integrated,
deployment is rapid and smooth.46 These improvements are likely
to reduce the operative duration in future, but before
K. Ahmed et al. / International Journal of Surgery 7 (2009) 431–440438implementation into the clinical practice evidence on clinical safety
is required.
Other disadvantages are lack of tactile and tensile feedback,
therefore the surgeon has to rely on visual cues to estimate the
tension exerted on tissue. In order to avoid injuries, particular care
must be taken with tissue handling.47 Robot-assisted laparoscopic
colectomy and other colorectal procedures require further evalua-
tion as regards to the oncological and functional outcomes, before
introduction to routine practice. Role of robotics is still limited in
cases requiring multi-quadrant surgery.48
10. Future developments
The advent of robotics has clearly taken surgical technology to
a new level. In conventional laparoscopy the visual experience is
limited to 2-D but da Vinci system offers the surgeon a 3-D view.
Although it improves the dexterity, limited tactile feedback is
a major compromise. Currently a lot of research is underway to
overcome this barrier. In 2006, Schostek et al. successfully incor-
porated a tactile sensor system in a laparoscopic grasper for
surgical palpation in minimally invasive surgery. The tactile data is
then presented visually to the surgeon. The system has been tested
in the experimental settings.49 Akinbiyi et al. have designed
a similar systemwhich is integrated into da Vinci system.50 Fischer
et al. have designed a system inwhich tactile data is fed as vibration
onto surgeon’s ﬁngertips.51
To date, robots have been widely used and tested for laparo-
scopic surgery. With the emergence of Natural Oriﬁce Trans-
lumination Endoscopic Surgery (NOTES) as a no scar surgical
option, the role of robots has generated a renewed interest. On
animal models Haber et al. performed pyeloplasties and nephrec-
tomies using da Vinci robotic arms placed per-vaginally and
reported a signiﬁcantly enhanced experience of intracorporeal
suturing.52
Research is also underway to develop freely mobile robots to
reduce fulcrum effect, improve dexterity and visualisation inside
the peritoneal cavity.53 Rentschler et al. have designed an unteth-
ered robot which can be inserted through the mouth and then
through a gastrostomy into the peritoneal cavity for remote
controlled exploration.54
The experience with robotic assisted remote telesurgery has
opened up exciting possibilities of surgeons operating in extreme
environments such as isolated locations or on battleﬁeld front-
lines.55 Anvari et al. recently reported the McMaster experience in
telepresence surgery. Between 2003 and 2005, 22 remote tele-
robotic operations were performed between the teaching centre
and a remote provincial hospital over 350 km away.56,57 Time
delays in telecommunication of 150–200 ms were experienced
during most procedures, and the surgeons found that when the
delay exceeded 250 ms, performing tasks telerobotically became
slow and less accurate. More work is being carried out to improve
this technology.
Recently, a prototype intra-abdominal mobile robot with the
potential to enhance the safety of minimal access surgery has been
developed. Under endoscopic control, a gastrotomy was created,
and the miniature robot was deployed into the abdominal cavity
under remote control. The robot is 12 mm in diameter and 75 mm
in length. This prototype endoluminal mobile robot was connected
to a power cable during the porcine surgery. A wireless in vivo
mobile robot also has been developed. The gastrostomy incision
was successfully closed endoscopically using two endoclips and
one endoloop. The robot was then retracted back through the
oesophagus.54
Robotic systems that are interfaced with computed tomography,
magnetic resonance imaging scans and ultrasound information cancreate a virtual surgical environment. This virtual scenario enables
simulated surgery to be performed based on a patient’s individual
imaging information, facilitating the preparation of operative
strategies for challenging and complex cases.58
The surgical trauma may be reduced without compromising
surgical access by using a family of robots working together inside
the abdominal cavity after simple insertion through the oesoph-
agus. Though these developments are still in experimental stages,
they forecast a showcase for the surgery of tomorrow. Moreover,
the introduction of robotic surgery into operating theatres also
poses a challenge to the existing theatre design. Most of the
theatres have been designed for the conventional surgical proce-
dures. Over the passage of time very limited modiﬁcations have
been made to accommodate the laparoscopic stacks. New theatre
designs such as Karl Storz OR1 have integrated the laparoscopic
stacks into manoeuvrable ceiling mounted columns with high
deﬁnition capabilities and surround screens. The controls for the
camera and insufﬂators have also been modernized for quick and
easy access. Audio and video recording capabilities are more
sophisticated to promote retrospective learning, research and
mentoring. In order to improve theatre ergonomics, the design of
future operating theatres needs a considerable transformation.5911. Conclusions
Robotic surgery appears to have a signiﬁcantly potential role in
pelvic surgery. Just as conventional laparoscopic surgery has
proven to be a transitional technology, the current generation of
surgical robots are likely to be replaced bymore efﬁcient machines.
In the meantime suitably designed randomised clinical trials for
appropriate procedures are prudent in order to obtain the outcome
data necessary to convince the critics of robotic pelvic surgery. The
required data include studies showing convenience of the surgeon,
beneﬁt to the patient and comparable or better long-term
outcomes.
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